The sub-variant accounted for about 30% of cases in the first week of January, higher than the 27.6% the CDC estimated last week.

(Reporting by Khushi Mandowara and Sriparna Roy in Bengaluru; Editing by Maju Samuel and Shounak Dasgupta)